BDBM451803 US10710980, Example 35::US10947218, Example 35

SMILES: Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1

InChI Key: InChIKey=RQXROVVCXFAAOM-GXLPGVSKSA-N

Data: 14 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 14 hits for monomerid = 451803   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Activin receptor type-1 [172-499] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	17	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description The assays were performed in 384-well, low volume microtiter assay plates in a final reaction volume of 6 ul. Dose-response curves were generated by ...				US Patent US10710980 (2020)
					More data for this Ligand-Target Pair
Bone morphogenetic protein receptor type-1A [198-525] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	903	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description The assays were performed in 384-well, low volume microtiter assay plates in a final reaction volume of 6 ul. Dose-response curves were generated by ...				US Patent US10710980 (2020)
					More data for this Ligand-Target Pair
Activin receptor type-1 [172-499] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description In the applied method, this separation takes place inside a chip that contains a complex capillary system for simultaneous analysis of 12 samples (“1...				US Patent US10710980 (2020)
					More data for this Ligand-Target Pair
Activin receptor type-1 [172-499,R206H] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description In the applied method, this separation takes place inside a chip that contains a complex capillary system for simultaneous analysis of 12 samples (“1...				US Patent US10710980 (2020)
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase receptor R3 [166-493] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	283	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description In the applied method, this separation takes place inside a chip that contains a complex capillary system for simultaneous analysis of 12 samples (“1...				US Patent US10710980 (2020)
					More data for this Ligand-Target Pair
TGF-beta receptor type-1 [162-503] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.73E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description In the applied method, this separation takes place inside a chip that contains a complex capillary system for simultaneous analysis of 12 samples (“1...				US Patent US10710980 (2020)
					More data for this Ligand-Target Pair
Bone morphogenetic protein receptor type-1B (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
NOVARTIS AG US Patent					Assay Description A kinase selectivity panel which measures substrate peptide phosphorylation was set-up for wild-type ALK2 (aa172-499), ALK2 FOP mutant (aa172-499 R20...				US Patent US10947218 (2021)
					More data for this Ligand-Target Pair
Activin receptor type-1 [172-499] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	17	n/a	n/a	n/a	n/a	n/a	n/a
NOVARTIS AG US Patent					Assay Description A kinase selectivity panel which measures autophosphorylation using the ADP-Glo Kinase Assay (Promega, V9101) was set-up for wild-type ALK2 (aa172-49...				US Patent US10947218 (2021)
					More data for this Ligand-Target Pair
Bone morphogenetic protein receptor type-1A [198-525] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	903	n/a	n/a	n/a	n/a	n/a	n/a
NOVARTIS AG US Patent					Assay Description A kinase selectivity panel which measures autophosphorylation using the ADP-Glo Kinase Assay (Promega, V9101) was set-up for wild-type ALK2 (aa172-49...				US Patent US10947218 (2021)
					More data for this Ligand-Target Pair
Activin receptor type-1 [172-499] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
NOVARTIS AG US Patent					Assay Description A kinase selectivity panel which measures substrate peptide phosphorylation was set-up for wild-type ALK2 (aa172-499), ALK2 FOP mutant (aa172-499 R20...				US Patent US10947218 (2021)
					More data for this Ligand-Target Pair
Activin receptor type-1 [172-499,R206H] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
NOVARTIS AG US Patent					Assay Description A kinase selectivity panel which measures substrate peptide phosphorylation was set-up for wild-type ALK2 (aa172-499), ALK2 FOP mutant (aa172-499 R20...				US Patent US10947218 (2021)
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase receptor R3 [166-493] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	283	n/a	n/a	n/a	n/a	n/a	n/a
NOVARTIS AG US Patent					Assay Description A kinase selectivity panel which measures substrate peptide phosphorylation was set-up for wild-type ALK2 (aa172-499), ALK2 FOP mutant (aa172-499 R20...				US Patent US10947218 (2021)
					More data for this Ligand-Target Pair
TGF-beta receptor type-1 [162-503] (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.73E+3	n/a	n/a	n/a	n/a	n/a	n/a
NOVARTIS AG US Patent					Assay Description A kinase selectivity panel which measures substrate peptide phosphorylation was set-up for wild-type ALK2 (aa172-499), ALK2 FOP mutant (aa172-499 R20...				US Patent US10947218 (2021)
					More data for this Ligand-Target Pair
Bone morphogenetic protein receptor type-1B (Homo sapiens (Human))	BDBM451803 (US10710980, Example 35 | US10947218, Example 35) Show SMILES Nc1ncc(cc1C(=O)NC12CCC(O)(CC1)CC2)-c1ccc(cc1)[C@]12C[C@H]1CN(C2)C1CCC(F)(F)CC1 |r| Show InChI InChI=1S/C31H38F2N4O2/c32-31(33)7-5-24(6-8-31)37-18-23-16-30(23,19-37)22-3-1-20(2-4-22)21-15-25(26(34)35-17-21)27(38)36-28-9-12-29(39,13-10-28)14-11-28/h1-4,15,17,23-24,39H,5-14,16,18-19H2,(H2,34,35)(H,36,38)/t23-,28?,29?,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description In the applied method, this separation takes place inside a chip that contains a complex capillary system for simultaneous analysis of 12 samples (“1...				US Patent US10710980 (2020)
					More data for this Ligand-Target Pair